Abstract
Influenza viruses undergo continuous genetic evolution and antigenic variation, creating significant challenges for vaccine development, disease prevention, and global public health management. This article reviews the major factors influencing influenza control, with particular emphasis on antigenic drift, vaccine effectiveness, and emerging preventive strategies. Annual seasonal vaccination remains the principal approach to reducing influenza-associated morbidity and severe complications; however, its effectiveness may be affected by the continuous evolution of circulating viral strains, delays in vaccine production, and antigenic changes arising during egg-based vaccine manufacturing. To overcome these limitations, next-generation approaches are being investigated, including universal influenza vaccines targeting conserved regions of hemagglutinin, improved adjuvanted formulations, and computational methods for predicting viral evolution. Artificial intelligence and genomic surveillance may further improve the identification of emerging variants and support more timely vaccine-strain selection. In addition, host-related factors such as immunosenescence, underlying comorbidities, immune imprinting, and repeated vaccination influence the magnitude and quality of vaccine-induced immune responses. At the population level, high vaccination coverage, accessible immunization services, and effective public health policies are essential for reducing transmission and protecting vulnerable groups. An integrated approach combining molecular surveillance, advanced vaccine technologies, individualized consideration of immune responses, and population-based prevention strategies is therefore essential for strengthening influenza control and preparedness for future outbreaks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
